Crux receives CE mark approval for inferior vena cava filter with BDR

Links shared publicly online about this topic.

0
total visits

Crux receives CE mark approval for inferior vena cava filter with BDR

Crux Biomedical announced it has received CE mark approval for their revolutionary inferior vena cava filter (IVCF) with bi-directional retrieval (BDR). Vena cava filters are designed to trap blood clots that can lead to a potentially fatal pulmonary embolism (PE). Each year in the United States, approximately 600,000 patients develop a PE and an estimated 200,000 deaths occur.

View full resource at news-medical.net

Tags: Pulmonary Embolism, Thrombotic Event, Blood Clot, Pulmonology, Biomed, Mortality